Sunday November 22 2009 | Biotechnology feed | All feeds
|
|
|
Meyer Pharmaceuticals, LLC
Download detailed PDF Members: Meyer Pharmaceuticals, LLC is a biopharmaceutical company dedicated to researching and developing innovative therapies for the treatment of inflammatory diseases and related disorders. Our therapeutic targets (rheumatoid arthritis, osteoarthritis, severe plaque psoriasis, inflammatory bowel disease, and sepsis) afflict over 60 million people worldwide. Our business strategy is to use our state-of-the-art capabilities to identify, evaluate, research and develop products through proof-of-concept clinical testing. We intend to pursue later stage clinical development, manufacturing, sales and marketing through strategic alliances with larger pharmaceutical or biotechnology partners. We continue to in-license complementary technology to strengthen the current pipeline. Our long-term plan is to develop products through all stages of clinical testing and to market our products.
This page has been viewed 471 times since April 2007, the link to the organisation's website has been followed 84 times Recent Search Terms used to find this page: meyer pharmaceuticals | meyer pharma advertising | meyer pharma | meyer pharmaceuticals | meyer pharmaceuticals | meyer pharmaceutical | meyer | meyer pharmaceuticals | meyer pharmaceuticals | . Search for more companies in Irvine Search for more companies in California This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for Meyer Pharmaceuticals, LLC | ||||||||||||||||||||||||||
|
Nothing in this website should be used in
place of personal medical advice from your own qualified medical
practitioner. |
All rights reserved. All other trademarks recognized. |
|
